News

Mission

The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

DPP4 Inhibitors for Target Therapy Resistance in Renal Cell Carcinoma

News

September 20, 2023

PRESS RELEASE: On September 15, 2023, a new editorial was published in Oncotarget, entitled, “Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma.” continue reading »

Real-Time Live Tissue Sensitivity Assay for Pancreatic Adenocarcinoma

News

September 19, 2023

PRESS RELEASE: On September 15, 2023, a new research paper was published in Oncotarget, entitled, “Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma.” continue reading »

Development of a Noise Barometer for Measuring Epigenetic Pressure of Aging and Disease

Aging

September 18, 2023

PRESS RELEASE: A new priority research paper was published on the cover of Aging's Volume 15, Issue 17, entitled, “Fail-tests of DNA methylation clocks, and development of a noise barometer for measuring epigenetic pressure of aging and disease.” continue reading »

Systemic Treatment for Brain Metastasis in HER2-Positive Advanced Breast Cancer

News

September 13, 2023

PRESS RELEASE: On July 7, 2023, a new editorial was published in Oncotarget, entitled, “Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?” continue reading »

Increased BRD4-L and BRD4-S Promotes Chemotherapy Resistance in Ovarian Carcinoma

Genes & Cancer

September 13, 2023

PRESS RELEASE: On September 12, 2023, a new research paper was published in Genes & Cancer, entitled, “Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma.” continue reading »

« Previous 1 … 60 61 62 63 64 … 114 Next »